Ranitidine hydrochloride and Peripheral nerve lesion - a phase IV clinical study of FDA data

Summary:

Peripheral nerve lesion is reported as a side effect among people who take Ranitidine hydrochloride (ranitidine hydrochloride), especially for people who are female, have been taking the drug for 6 - 12 months also take Pantoprazole, and have Fibromyalgia.

The phase IV clinical study analyzes which people have Peripheral nerve lesion when taking Ranitidine hydrochloride. It is created by eHealthMe based on reports of 75,820 people who have side effects when taking Ranitidine hydrochloride from the FDA, and is updated regularly.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 76,413 Ranitidine hydrochloride users. Check the latest studies of Ranitidine hydrochloride.

What is Peripheral nerve lesion?

Peripheral nerve lesion is found to be associated with 103 drugs and 197 conditions by eHealthMe. Check the latest studies of Peripheral nerve lesion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

75,820 people reported to have side effects when taking Ranitidine hydrochloride.
Among them, 16 people (0.02%) have Peripheral nerve lesion.

Could Ranitidine hydrochloride cause Peripheral nerve lesion?

Among these 16 people:

How long have people been on Ranitidine hydrochloride when they have Peripheral nerve lesion? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Peripheral nerve lesion when taking Ranitidine hydrochloride? *

  • female: 100 %
  • male: 0.0 %

What are other drugs people take besides Ranitidine hydrochloride? *

  1. Celebrex: 16 people, 100.00%
  2. Pantoprazole: 16 people, 100.00%
  3. Anafranil: 10 people, 62.50%
  4. Diclofenac: 9 people, 56.25%
  5. Magnesium: 9 people, 56.25%
  6. Lyrica: 6 people, 37.50%
  7. Duspatal: 5 people, 31.25%
  8. Tramadol Hydrochloride: 2 people, 12.50%
  9. Ranitidine: 2 people, 12.50%
  10. Aspirin: 2 people, 12.50%

What are other side effects people have besides Peripheral nerve lesion? *

  1. Haematoma (collection of blood outside the blood vessels): 16 people, 100.00%
  2. Scar: 16 people, 100.00%
  3. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 16 people, 100.00%
  4. Nausea (feeling of having an urge to vomit): 16 people, 100.00%
  5. Malaise (a feeling of general discomfort or uneasiness): 16 people, 100.00%
  6. Facial Paresis (weakness in facial muscle movement): 16 people, 100.00%
  7. Osteopenia (a condition where bone mineral density is lower than normal): 16 people, 100.00%
  8. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 16 people, 100.00%
  9. Depression: 16 people, 100.00%
  10. Pain: 16 people, 100.00%

What are the existing conditions these people have? *

  1. Pain: 16 people, 100.00%
  2. Fibromyalgia (a long-term condition which causes pain all over the body): 16 people, 100.00%
  3. Myosclerosis (hardening of muscle tissue): 9 people, 56.25%
  4. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 6 people, 37.50%
  5. Gastritis - Chronic (long lasting inflammation of stomach): 6 people, 37.50%
  6. Arrhythmias (irregular heartbeat): 6 people, 37.50%
  7. Vitamin B12 Abnormal: 5 people, 31.25%
  8. Thrombosis (formation of a blood clot inside a blood vessel): 5 people, 31.25%
  9. Joint Pain: 2 people, 12.50%
  10. Blood Iron Abnormal: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine hydrochloride and have Peripheral nerve lesion?

- Check whether Peripheral nerve lesion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ranitidine hydrochloride:

Peripheral nerve lesion treatments and more:

How severe was Peripheral nerve lesion and when was it recovered:

Expand to all the drugs that have ingredients of ranitidine hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranitidine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peripheral nerve lesion:

Browse all the conditions that are associated with Peripheral nerve lesion:


How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride (the active ingredients of Ranitidine hydrochloride) and Ranitidine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: